
FDA Direction Revealed in Gottlieb’s Final Statements
On March 28, FDA Commissioner Scott Gottlieb appeared before the Senate Subcommittee on Appropriations for the last time in his role as c…
we are committed to delivering innovative solutions that drive growth and add value to our clients. With a team of experienced professionals and a passion for excellence.

On March 28, FDA Commissioner Scott Gottlieb appeared before the Senate Subcommittee on Appropriations for the last time in his role as c…

On March 12, a recall notice was posted on the FDA website for two production lots of Pillsbury Unbleached All-Purpose Flour due to possi…

By Eric Edmunds The basic definition of CBD is fairly clear: As the abbreviation for cannabidiol, CBD is a naturally occurring,…

With the first of the compliance dates for FSMA’s Intentional Adulteration (IA) Rule only four months away, FDA has released the second o…

In February’s “FSMA Friday and Regulatory Update” webinar, Eric Edmunds, JD, of The Acheson Group (TAG) discussed the National Bioenginee…

Although aspects of the eight-year-old Food Safety Modernization Act are still being rolled out, FDA has taken on a new modernization end…

Since 2016, there have been more than 30 recalls of raw pet foods due to the potential or presence of microbiological contamination, prim…

FDA’s use of whole genome sequencing (WGS) was a significant factor in its late 2018 investigation of an E. coli outbreak tracked to roma…

As of January 15, 2019, the Safe Food for Canadians Regulations (SFCR) came into force. However, not all the provisions needed to be met …
© 2026 The Acheson Group. All rights reserved